{"entity":{"type":"insider","cik":"0001484729","url":"/insider/0001484729","json_url":"/insider/0001484729.json","name":"Leheny A. Rachel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":16,"first":"2010-09-24","last":"2025-07-21","span_basis":"filed_date"},"name_variants":[{"name":"Leheny A. Rachel","source":"filing","n_filings":16,"first_seen":"2010-09-24","last_seen":"2025-07-21"}],"transactions":[{"id":5125465,"accession":"0001415889-25-020052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-020052","line_url":"/filing/0001415889-25-020052#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (CHIEF EXECUTIVE OFFICER), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":3400.0,"total_display":"3,400.00","total_whole":"3,400","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-21","scope":"insider"},{"id":5040128,"accession":"0001415889-25-019816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-019816","line_url":"/filing/0001415889-25-019816#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (CHIEF EXECUTIVE OFFICER), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":6175.0,"total_display":"6,175.00","total_whole":"6,175","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-15","scope":"insider"},{"id":2102374,"accession":"0001415889-24-025880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-025880","line_url":"/filing/0001415889-24-025880#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (CHIEF EXECUTIVE OFFICER), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":130926.0,"shares_owned_after_display":"130,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-01","scope":"insider"},{"id":3263369,"accession":"0001415889-24-022361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-022361","line_url":"/filing/0001415889-24-022361#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (CHIEF EXECUTIVE OFFICER), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.1898,"price_display":"4.19","price_state":"stated","total_value":4189.8,"total_display":"4,189.80","total_whole":"4,190","shares_owned_after":110926.0,"shares_owned_after_display":"110,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-27","scope":"insider"},{"id":8156119,"accession":"0001209191-23-054770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054770","line_url":"/filing/0001209191-23-054770#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.34,"price_display":"3.34","price_state":"stated","total_value":6680.0,"total_display":"6,680.00","total_whole":"6,680","shares_owned_after":18840.0,"shares_owned_after_display":"18,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-08","scope":"insider"},{"id":8405613,"accession":"0001209191-23-054633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054633","line_url":"/filing/0001209191-23-054633#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2440.0,"shares_display":"2,440","price_per_share":3.1208,"price_display":"3.12","price_state":"stated","total_value":7614.752,"total_display":"7,614.75","total_whole":"7,615","shares_owned_after":16840.0,"shares_owned_after_display":"16,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-06","filed_date":"2023-11-07","scope":"insider"},{"id":8681320,"accession":"0001209191-23-054577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054577","line_url":"/filing/0001209191-23-054577#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":14250.0,"total_display":"14,250.00","total_whole":"14,250","shares_owned_after":14400.0,"shares_owned_after_display":"14,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-06","scope":"insider"},{"id":8154251,"accession":"0001209191-23-036127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-036127","line_url":"/filing/0001209191-23-036127#line-2","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":2100.0,"total_display":"2,100.00","total_whole":"2,100","shares_owned_after":9328.0,"shares_owned_after_display":"9,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-09","scope":"insider"},{"id":9272027,"accession":"0001209191-23-037586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037586","line_url":"/filing/0001209191-23-037586#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.225,"price_display":"5.22","price_state":"stated","total_value":5225.0,"total_display":"5,225.00","total_whole":"5,225","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-15","scope":"insider"},{"id":8154242,"accession":"0001209191-23-036127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-036127","line_url":"/filing/0001209191-23-036127#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":928.0,"shares_display":"928","price_per_share":5.2269,"price_display":"5.23","price_state":"stated","total_value":4850.5632,"total_display":"4,850.56","total_whole":"4,851","shares_owned_after":8928.0,"shares_owned_after_display":"8,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8112726,"accession":"0001209191-23-035609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035609","line_url":"/filing/0001209191-23-035609#line-2","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.2478,"price_display":"5.25","price_state":"stated","total_value":5247.8,"total_display":"5,247.80","total_whole":"5,248","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-08","scope":"insider"},{"id":8112721,"accession":"0001209191-23-035609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035609","line_url":"/filing/0001209191-23-035609#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.1287,"price_display":"5.13","price_state":"stated","total_value":5128.7,"total_display":"5,128.70","total_whole":"5,129","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-08","scope":"insider"},{"id":8439067,"accession":"0001209191-23-034646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034646","line_url":"/filing/0001209191-23-034646#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":4800.0,"total_display":"4,800.00","total_whole":"4,800","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":8545373,"accession":"0001209191-23-033461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033461","line_url":"/filing/0001209191-23-033461#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":4210.0,"total_display":"4,210.00","total_whole":"4,210","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-01","scope":"insider"},{"id":7922215,"accession":"0001209191-23-032024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-032024","line_url":"/filing/0001209191-23-032024#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.3439,"price_display":"3.34","price_state":"stated","total_value":10031.7,"total_display":"10,031.70","total_whole":"10,032","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":9271999,"accession":"0001209191-23-034642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034642","line_url":"/filing/0001209191-23-034642#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.698,"price_display":"2.70","price_state":"stated","total_value":2698.0,"total_display":"2,698.00","total_whole":"2,698","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-06-05","scope":"insider"},{"id":8042670,"accession":"0001209191-23-030778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030778","line_url":"/filing/0001209191-23-030778#line-1","is_derivative":false,"issuer_cik":"0001484729","issuer_name":"CalciMedica, Inc.","issuer_ticker":"CALC","issuer_name_source":null,"issuer_url":"/issuer/0001484729","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":2690.0,"total_display":"2,690.00","total_whole":"2,690","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":7733072,"accession":"0001209191-10-047487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-047487","line_url":"/filing/0001209191-10-047487#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001484729","owner_name":"Leheny A. Rachel","owner_display_name":"Leheny A. Rachel","owner_url":"/insider/0001484729","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":1423896.0,"shares_owned_after_display":"1,423,896","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-24","filed_date":"2010-09-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001534133","name":"CalciMedica, Inc.","url":"/issuer/0001534133","role":"Director, Officer (CHIEF EXECUTIVE OFFICER), Ten percent owner","n_filings":15,"first_seen":"2023-05-18","last_seen":"2025-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Director","n_filings":1,"first_seen":"2010-09-24","last_seen":"2010-09-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001484729","retrieved_at":"2026-08-22T22:15:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}